Sign In

Login

Password

Forgot Password ? Sign Up

Melatonin receptor agonist (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Melatonin receptor agonist" in English language version.

refsWebsite
Global rank English rank
20nih.gov
4th place
4th place
17doi.org
2nd place
2nd place
5semanticscholar.org
11th place
8th place
3fda.gov
447th place
338th place
2web.archive.org
1st place
1st place
2neurim.com
low place
low place
1harvard.edu
18th place
17th place
1handle.net
102nd place
76th place
1neurotransmitter.net
low place
low place

doi.org

  • Rivara S, Mor M, Bedini A, Spadoni G, Tarzia G (2008). "Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders". Current Topics in Medicinal Chemistry. 8 (11): 954–968. doi:10.2174/156802608784936719. PMID 18673165.
  • Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zisapel N, et al. (July 2008). "Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways". Progress in Neurobiology. 85 (3): 335–353. doi:10.1016/j.pneurobio.2008.04.001. PMID 18571301. S2CID 42549910.
  • Sugden D, Davidson K, Hough KA, Teh MT (October 2004). "Melatonin, melatonin receptors and melanophores: a moving story". Pigment Cell Research. 17 (5): 454–460. doi:10.1111/j.1600-0749.2004.00185.x. PMID 15357831.
  • Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J (September 2010). "International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors". Pharmacological Reviews. 62 (3): 343–380. doi:10.1124/pr.110.002832. PMC 2964901. PMID 20605968.
  • Witt-Enderby PA, Bennett J, Jarzynka MJ, Firestine S, Melan MA (April 2003). "Melatonin receptors and their regulation: biochemical and structural mechanisms". Life Sciences. 72 (20): 2183–2198. doi:10.1016/S0024-3205(03)00098-5. PMID 12628439.
  • Wang Q, Lu Q, Guo Q, Teng M, Gong Q, Li X, et al. (January 2022). "Structural basis of the ligand binding and signaling mechanism of melatonin receptors". Nature Communications. 13 (1): 454. Bibcode:2022NatCo..13..454W. doi:10.1038/s41467-022-28111-3. PMC 8786939. PMID 35075127.
  • de Bodinat C, Guardiola-Lemaitre B, Mocaër E, Renard P, Muñoz C, Millan MJ (August 2010). "Agomelatine, the first melatonergic antidepressant: discovery, characterization and development". Nature Reviews. Drug Discovery. 9 (8): 628–642. doi:10.1038/nrd3140. PMID 20577266. S2CID 54524999.
  • Ferguson SA, Rajaratnam SM, Dawson D (February 2010). "Melatonin agonists and insomnia". Expert Review of Neurotherapeutics. 10 (2): 305–318. doi:10.1586/ern.10.1. PMID 20136385. S2CID 25430719.
  • Rajaratnam SM, Cohen DA, Rogers NL (2009). "Melatonin and Melatonin Analogues". Sleep Medicine Clinics. 4 (2): 179–93. doi:10.1016/j.jsmc.2009.02.007.
  • Dubocovich ML (December 2007). "Melatonin receptors: role on sleep and circadian rhythm regulation". Sleep Medicine. 8 (Suppl 3): 34–42. doi:10.1016/j.sleep.2007.10.007. PMID 18032103.
  • Boutin JA, Witt-Enderby PA, Sotriffer C, Zlotos DP (October 2020). "Melatonin receptor ligands: A pharmaco-chemical perspective". Journal of Pineal Research. 69 (3): e12672. doi:10.1111/jpi.12672. PMID 32531076.
  • Elisi GM, Scalvini L, Lodola A, Bedini A, Spadoni G, Rivara S (April 2022). "In silico drug discovery of melatonin receptor ligands with therapeutic potential". Expert Opinion on Drug Discovery. 17 (4): 343–354. doi:10.1080/17460441.2022.2043846. PMID 35255751. S2CID 247295193.
  • Rivara S, Diamantini G, Di Giacomo B, Lamba D, Gatti G, Lucini V, et al. (May 2006). "Reassessing the melatonin pharmacophore--enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue". Bioorganic & Medicinal Chemistry. 14 (10): 3383–3391. doi:10.1016/j.bmc.2005.12.053. PMID 16431121.
  • Rivara S, Mor M, Silva C, Zuliani V, Vacondio F, Spadoni G, et al. (April 2003). "Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation". Journal of Medicinal Chemistry. 46 (8): 1429–1439. doi:10.1021/jm020982d. PMID 12672242.
  • Mari M, Elisi GM, Bedini A, Lucarini S, Retini M, Lucini V, et al. (December 2022). "2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT1 and MT2 receptors". European Journal of Medicinal Chemistry. 243: 114762. doi:10.1016/j.ejmech.2022.114762. hdl:11576/2704150. PMID 36150258. S2CID 252295726.
  • Stauch B, Johansson LC, Cherezov V (April 2020). "Structural insights into melatonin receptors". The FEBS Journal. 287 (8): 1496–1510. doi:10.1111/febs.15128. PMC 7174090. PMID 31693784.
  • Popovska-Gorevski M, Dubocovich ML, Rajnarayanan RV (February 2017). "Carbamate Insecticides Target Human Melatonin Receptors". Chemical Research in Toxicology. 30 (2): 574–582. doi:10.1021/acs.chemrestox.6b00301. PMC 5318275. PMID 28027439.

fda.gov

fda.gov

accessdata.fda.gov

handle.net

hdl.handle.net

harvard.edu

ui.adsabs.harvard.edu

neurim.com

neurotransmitter.net

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Rivara S, Mor M, Bedini A, Spadoni G, Tarzia G (2008). "Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders". Current Topics in Medicinal Chemistry. 8 (11): 954–968. doi:10.2174/156802608784936719. PMID 18673165.
  • Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zisapel N, et al. (July 2008). "Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways". Progress in Neurobiology. 85 (3): 335–353. doi:10.1016/j.pneurobio.2008.04.001. PMID 18571301. S2CID 42549910.
  • Sugden D, Davidson K, Hough KA, Teh MT (October 2004). "Melatonin, melatonin receptors and melanophores: a moving story". Pigment Cell Research. 17 (5): 454–460. doi:10.1111/j.1600-0749.2004.00185.x. PMID 15357831.
  • Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J (September 2010). "International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors". Pharmacological Reviews. 62 (3): 343–380. doi:10.1124/pr.110.002832. PMC 2964901. PMID 20605968.
  • Witt-Enderby PA, Bennett J, Jarzynka MJ, Firestine S, Melan MA (April 2003). "Melatonin receptors and their regulation: biochemical and structural mechanisms". Life Sciences. 72 (20): 2183–2198. doi:10.1016/S0024-3205(03)00098-5. PMID 12628439.
  • Wang Q, Lu Q, Guo Q, Teng M, Gong Q, Li X, et al. (January 2022). "Structural basis of the ligand binding and signaling mechanism of melatonin receptors". Nature Communications. 13 (1): 454. Bibcode:2022NatCo..13..454W. doi:10.1038/s41467-022-28111-3. PMC 8786939. PMID 35075127.
  • de Bodinat C, Guardiola-Lemaitre B, Mocaër E, Renard P, Muñoz C, Millan MJ (August 2010). "Agomelatine, the first melatonergic antidepressant: discovery, characterization and development". Nature Reviews. Drug Discovery. 9 (8): 628–642. doi:10.1038/nrd3140. PMID 20577266. S2CID 54524999.
  • Ferguson SA, Rajaratnam SM, Dawson D (February 2010). "Melatonin agonists and insomnia". Expert Review of Neurotherapeutics. 10 (2): 305–318. doi:10.1586/ern.10.1. PMID 20136385. S2CID 25430719.
  • Dubocovich ML (December 2007). "Melatonin receptors: role on sleep and circadian rhythm regulation". Sleep Medicine. 8 (Suppl 3): 34–42. doi:10.1016/j.sleep.2007.10.007. PMID 18032103.
  • Boutin JA, Witt-Enderby PA, Sotriffer C, Zlotos DP (October 2020). "Melatonin receptor ligands: A pharmaco-chemical perspective". Journal of Pineal Research. 69 (3): e12672. doi:10.1111/jpi.12672. PMID 32531076.
  • Elisi GM, Scalvini L, Lodola A, Bedini A, Spadoni G, Rivara S (April 2022). "In silico drug discovery of melatonin receptor ligands with therapeutic potential". Expert Opinion on Drug Discovery. 17 (4): 343–354. doi:10.1080/17460441.2022.2043846. PMID 35255751. S2CID 247295193.
  • Rivara S, Diamantini G, Di Giacomo B, Lamba D, Gatti G, Lucini V, et al. (May 2006). "Reassessing the melatonin pharmacophore--enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue". Bioorganic & Medicinal Chemistry. 14 (10): 3383–3391. doi:10.1016/j.bmc.2005.12.053. PMID 16431121.
  • Rivara S, Mor M, Silva C, Zuliani V, Vacondio F, Spadoni G, et al. (April 2003). "Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation". Journal of Medicinal Chemistry. 46 (8): 1429–1439. doi:10.1021/jm020982d. PMID 12672242.
  • Mari M, Elisi GM, Bedini A, Lucarini S, Retini M, Lucini V, et al. (December 2022). "2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT1 and MT2 receptors". European Journal of Medicinal Chemistry. 243: 114762. doi:10.1016/j.ejmech.2022.114762. hdl:11576/2704150. PMID 36150258. S2CID 252295726.
  • Stauch B, Johansson LC, Cherezov V (April 2020). "Structural insights into melatonin receptors". The FEBS Journal. 287 (8): 1496–1510. doi:10.1111/febs.15128. PMC 7174090. PMID 31693784.
  • Popovska-Gorevski M, Dubocovich ML, Rajnarayanan RV (February 2017). "Carbamate Insecticides Target Human Melatonin Receptors". Chemical Research in Toxicology. 30 (2): 574–582. doi:10.1021/acs.chemrestox.6b00301. PMC 5318275. PMID 28027439.

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

  • Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zisapel N, et al. (July 2008). "Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways". Progress in Neurobiology. 85 (3): 335–353. doi:10.1016/j.pneurobio.2008.04.001. PMID 18571301. S2CID 42549910.
  • de Bodinat C, Guardiola-Lemaitre B, Mocaër E, Renard P, Muñoz C, Millan MJ (August 2010). "Agomelatine, the first melatonergic antidepressant: discovery, characterization and development". Nature Reviews. Drug Discovery. 9 (8): 628–642. doi:10.1038/nrd3140. PMID 20577266. S2CID 54524999.
  • Ferguson SA, Rajaratnam SM, Dawson D (February 2010). "Melatonin agonists and insomnia". Expert Review of Neurotherapeutics. 10 (2): 305–318. doi:10.1586/ern.10.1. PMID 20136385. S2CID 25430719.
  • Elisi GM, Scalvini L, Lodola A, Bedini A, Spadoni G, Rivara S (April 2022). "In silico drug discovery of melatonin receptor ligands with therapeutic potential". Expert Opinion on Drug Discovery. 17 (4): 343–354. doi:10.1080/17460441.2022.2043846. PMID 35255751. S2CID 247295193.
  • Mari M, Elisi GM, Bedini A, Lucarini S, Retini M, Lucini V, et al. (December 2022). "2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT1 and MT2 receptors". European Journal of Medicinal Chemistry. 243: 114762. doi:10.1016/j.ejmech.2022.114762. hdl:11576/2704150. PMID 36150258. S2CID 252295726.

web.archive.org